Literature DB >> 8494539

Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases.

K W Bock1, A Forster, H Gschaidmeier, M Brück, P Münzel, W Schareck, S Fournel-Gigleux, B Burchell.   

Abstract

Stably expressed human and rat phenol UDP-glucuronosyltransferases (UGTs) of the UGT1 complex (HlugP1, HlugP4 and 3-methylcholanthrene-inducible rat UGT1A1, the latter considered to be an orthologous enzyme to HlugP1) have been used to investigate the role of UGTs in paracetamol glucuronidation. Kinetic analysis of recombinant UGTs was compared to that of total UGT activities in liver microsomes. Paracetamol was found to be an overlapping substrate of several UGTs. It shows higher affinity for HlugP1 and rat UGT1A1 (apparent Km values of 2 and 3 mM, respectively) than for HlugP4 (Km = 50 mM) and other UGTs present in liver microsomes (Km values of > 12 mM). Glucuronidation of paracetamol with HlugP1 contrasts with that of 6-hydroxychrysene and of 4-methylumbelliferone, which are conjugated with higher affinity by HlugP4 than by HlugP1. Due to the wide tissue distribution of rat UGT1A1, paracetamol glucuronidation was also investigated in extrahepatic rat and human tissues. Paracetamol UGT activity was present and inducible by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat kidney, lung and spleen. It was also detected in human kidney. A selective cDNA probe for exon 1 of HlugP1 cross-reacted with mRNA from both human liver and kidney. The results demonstrate that paracetamol is conjugated by HlugP1 and its rat orthologue UGT1A1 with higher affinity than by HlugP4 and other UGTs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494539     DOI: 10.1016/0006-2952(93)90437-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  14 in total

Review 1.  Glucuronidation in humans. Pharmacogenetic and developmental aspects.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

2.  Salicytamide: a New Anti-inflammatory Designed Drug Candidate.

Authors:  Karen Marinho Maciel Guedes; Rosivaldo Santos Borges; Enéas Andrade Fontes-Júnior; Andressa Santa Brigida Silva; Luanna Melo Pereira Fernandes; Sabrina Carvalho Cartágenes; Ana Carla Godinho Pinto; Mallone Lopes Silva; Luana Melo Diogo Queiroz; José Luís Fernandes Vieira; Pergentino José Cunha Sousa; Cristiane Socorro Ferraz Maia
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

3.  PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.

Authors:  Liudmila L Mazaleuskaya; Katrin Sangkuhl; Caroline F Thorn; Garret A FitzGerald; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2015-08       Impact factor: 2.089

4.  Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.

Authors:  Yao Lu; Youxin Fang; Xunyi Wu; Chunlai Ma; Yue Wang; Lan Xu
Journal:  Eur J Clin Pharmacol       Date:  2016-11-29       Impact factor: 2.953

5.  Heterogeneity of paracetamol metabolism in Gilbert's syndrome.

Authors:  A Esteban; M Pérez-Mateo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Jan-Mar       Impact factor: 2.441

6.  Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum.

Authors:  Aida Kulo; Mariska Y Peeters; Karel Allegaert; Anne Smits; Jan de Hoon; Rene Verbesselt; Liesbeth Lewi; Marc van de Velde; Catherijne A J Knibbe
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

7.  The kinetic basis for age-associated changes in quercetin and genistein glucuronidation by rat liver microsomes.

Authors:  Bradley W Bolling; Michael H Court; Jeffrey B Blumberg; C-Y Oliver Chen
Journal:  J Nutr Biochem       Date:  2009-05-14       Impact factor: 6.048

8.  The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.

Authors:  Michael H Court; Marina Freytsis; Xueding Wang; Inga Peter; Chantal Guillemette; Suwagmani Hazarika; Su X Duan; David J Greenblatt; William M Lee
Journal:  J Pharmacol Exp Ther       Date:  2013-02-13       Impact factor: 4.030

9.  Induction of cytochrome P4501A by smoking or omeprazole in comparison with UDP-glucuronosyltransferase in biopsies of human duodenal mucosa.

Authors:  J Buchthal; K E Grund; A Buchmann; D Schrenk; P Beaune; K W Bock
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 10.  Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.

Authors:  Siavosh Naji-Talakar; Sheena Sharma; Leslie A Martin; Derek Barnhart; Bhagwat Prasad
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-01-20       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.